MIA
IMGN

MeadowBrook Investment Advisors’s Immunogen Inc IMGN Stock Holding History

MeadowBrook Investment Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,800
Closed -$53.4K – 350
2023
Q4 		$53.4K Buy
+1,800
New +$35.8K 0.05% 164

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MeadowBrook Investment Advisors's IMGN Position: Q1 2024 in Review

MeadowBrook Investment Advisors sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,800 shares — an estimated $53.4K sold.

MeadowBrook Investment Advisors first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $53.4K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • MeadowBrook Investment Advisors reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • MeadowBrook Investment Advisors sold 1,800 Immunogen Inc shares in Q1 2024, an estimated $53.4K.
  • MeadowBrook Investment Advisors first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • MeadowBrook Investment Advisors's Immunogen Inc position peaked at $53.4K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on MeadowBrook Investment Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.